By MANSUR SHAHEEN
FOR DAILYMAIL.COM
The current crop of COVID-19 vaccines may not be as effective against the Indian ‘Delta’ variant compared to the original strain of the virus, a new study suggests.
Researchers from the Mayo Clinic in Rochester, Minnesota, found that the Pfizer-BioNTech vaccine – the most commonly used shot in the U.S. – was only 42 percent effective against infection in July.
Click the link below to read the rest of this story.

Click here to get more news from the Bulldog
On the go, but don’t want to miss any Bulldog news? Go to the App Store and downloads apps for Bulldog Reports and The Bulldog Show to your Apple and Android mobile devices. It’s free!
In this article:COVID, COVID vaccine, COVID-19, DElta variant, Mayo Clinic, Minnesota, Moderna's Is 76% Effective, Pfizer, Pfizer-BioNTech, Pfizer's Covid Vaccine Is Only 42% Effective Against Delta Variant, Rochester

Click to comment